Abbott India and Redcliffe Labs have partnered to launch AlinIQ, a Clinical Decision Support system using Big Data Engines and AI to improve patient care and convenience in healthcare.

Redcliffe Labs is the first to adopt the AI-powered AlinIQ Clinical Decision Support system in the diagnostics sector. The cutting-edge platform aims to provide unmatched insights and recommendations, reshaping medical choices for consumers, clinicians, and healthcare professionals.

Big Data in healthcare presents challenges in clinical decision-making. Redcliffe Labs developed an AI-powered CDS System to convert extensive data into actionable insights, providing healthcare professionals with easily understandable, personalized, and user-friendly information.

The CDS system uses AI-driven algorithms for decision-making in patient cases, providing healthcare professionals with enriched insights and clinical recommendations for improved treatment choices.

Redcliffe Labs advances AI technology for personalized healthcare, promoting a healthier, brighter future for the Indian population through precise and precise methods.

Dheeraj Jain, Founder & MD, Redcliffe Labs said,

“At Redcliffe Labs, our unwavering commitment to advancing patient care through innovation and technology has led to the development of the AI based CDS system. Our state-of-the-art CDS represents a giant leap forward in the diagnostic healthcare sector, empowering our skilled clinicians with invaluable insights to provide the best possible care for our patients.”

Jamshyed Patrawala, Country Head of Abbott India, highlighted the integration as a significant milestone in the diagnostic sector. He envisioned an improved diagnostic landscape, aiding clinicians and providing convenience for individuals. This progress will enable thorough, personalized reports on health conditions, providing a comparative analysis.